Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Total Liabilities (2021 - 2025)

PAVmed has reported Total Liabilities over the past 5 years, most recently at $16.5 million for Q4 2025.

  • Quarterly results put Total Liabilities at $16.5 million for Q4 2025, down 56.19% from a year ago — trailing twelve months through Dec 2025 was $16.5 million (down 56.19% YoY), and the annual figure for FY2025 was $16.5 million, down 56.19%.
  • Total Liabilities for Q4 2025 was $16.5 million at PAVmed, up from $12.3 million in the prior quarter.
  • Over the last five years, Total Liabilities for PAVM hit a ceiling of $58.1 million in Q2 2024 and a floor of $3.3 million in Q1 2021.
  • Median Total Liabilities over the past 5 years was $28.6 million (2022), compared with a mean of $30.9 million.
  • Biggest five-year swings in Total Liabilities: skyrocketed 670.02% in 2022 and later tumbled 79.44% in 2025.
  • PAVmed's Total Liabilities stood at $7.6 million in 2021, then surged by 469.54% to $43.0 million in 2022, then surged by 32.73% to $57.1 million in 2023, then tumbled by 34.03% to $37.7 million in 2024, then tumbled by 56.19% to $16.5 million in 2025.
  • The last three reported values for Total Liabilities were $16.5 million (Q4 2025), $12.3 million (Q3 2025), and $12.5 million (Q2 2025) per Business Quant data.